Review of: "Risk of death derived from Hazard Ratio should not be communicated as Relative Risk reductions for death in cancer clinical trials. Intentional or inadvertent?"
In the article “Hazard Risk Reductions Should Not Be Communicated as Relative Risk Reductions for Death in Cancer Clinical Trials: Intentional or Inadvertent?” The authors aimed to explore a highly pertinent pitfall in the interpretation of an articl...